IBIO
iBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.25
+0.00%Margins
Gross margin
100.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.6%
Return on equity
-33.3%
Return on assets
-40.0%
Return on invested capital
0.00x
Asset turnover
-$23.2M
Cash from operations
$1.37
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026